Floatz logo

Cyclophosphamide

Neoplasm, Nerve Tissue

Hoffmann-La RocheSmall moleculePhase 3Dormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Neoplasm, Nerve Tissue cohort.

Asset / SponsorPhaseRating
Epirubicin
Hoffmann-La Roche
Phase 3BB
Pembrolizumab
Hoffmann-La Roche
Phase 3BB
TASADENOTUREV
DNAtrix, Inc.
Phase 2B

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →